Literature DB >> 18226316

Safety of a modification of the triage level for febrile children 6 to 36 months old using the Paediatric Canadian Triage and Acuity Scale.

Jocelyn Gravel1, Sergio Manzano, Michael Arsenault.   

Abstract

OBJECTIVE: The Paediatric Canadian Triage and Acuity Scale (PaedCTAS) stipulates that febrile patients who are 3 to 36 months old should be triaged to the PaedCTAS 3 "urgent" category. To optimize resource use, we implemented a protocol enabling these children to be down-triaged to the PaedCTAS 4 "less urgent" category if there was no sign of toxicity. Our objective was to evaluate the safety of this triage protocol modification.
METHODS: This retrospective cohort study evaluated all patients triaged in an urban tertiary pediatric hospital during a 6-month period between November 22, 2005, and May 22, 2006. Data were retrieved from the emergency department (ED) database and rates of hospitalization and intensive care unit (ICU) admission were compared for 4 groups: all patients triaged as urgent (level 3), all febrile patients from 3 to 36 months old triaged as urgent (level 3), all patients triaged as less urgent (level 4) and all febrile patients aged 3 to 36 months old who were down-triaged to less urgent (level 4).
RESULTS: There were 36,285 total ED visits during the study period, including 3477 febrile children who were 3 to 36 months old. Nurses down-triaged 1869 febrile children (54%) to the level-4 (less urgent) category and left 1322 (38%) in the level-3 (urgent) category. Hospitalization rate for down-triaged febrile patients was similar to that seen for all PaedCTAS 4 patients (2.4% v. 2.8%, 95% confidence interval for difference -0.3% to 1.1%). Down-triaged patients had significantly lower admission rates than those remaining in the level-3 (urgent) category (absolute risk reduction 10.7% standard deviation 1.9%, p<0.001). No down-triaged patient died or required ICU admission.
CONCLUSION: Febrile children aged 6 to 36 months who have no signs of toxicity can safely be down-triaged, based on triage nurse clinical judgement, to the less urgent PaedCTAS 4 category. This modification would affect the triage level of approximately 5% of all pediatric ED visits.

Entities:  

Mesh:

Year:  2008        PMID: 18226316     DOI: 10.1017/s1481803500009982

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


  6 in total

1.  Pediatric triage modifications based on vital signs: a nationwide study.

Authors:  Bongjin Lee; June Dong Park; Young Ho Kwak; Do Kyun Kim
Journal:  Clin Exp Emerg Med       Date:  2022-09-27

2.  Application of emergency severity index in pediatric emergency department.

Authors:  Lei Wang; Hong Zhou; Jing-Fang Zhu
Journal:  World J Emerg Med       Date:  2011

3.  Manchester triage system in paediatric emergency care: prospective observational study.

Authors:  M van Veen; Ewout W Steyerberg; Madelon Ruige; Alfred H J van Meurs; Jolt Roukema; Johan van der Lei; Henriette A Moll
Journal:  BMJ       Date:  2008-09-22

4.  Clinical Considerations When Applying Vital Signs in Pediatric Korean Triage and Acuity Scale.

Authors:  Bongjin Lee; Do Kyun Kim; June Dong Park; Young Ho Kwak
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

5.  Diversity in the emergency care for febrile children in Europe: a questionnaire study.

Authors:  Dorine Borensztajn; Shunmay Yeung; Nienke N Hagedoorn; Anda Balode; Ulrich von Both; Enitan D Carrol; Juan Emmanuel Dewez; Irini Eleftheriou; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Jethro Adam Herberg; Benno Kohlmaier; Emma Lim; Ian Maconochie; Federico Martinón-Torres; Ruud Nijman; Marko Pokorn; Franc Strle; Maria Tsolia; Gerald Wendelin; Dace Zavadska; Werner Zenz; Michael Levin; Henriette A Moll
Journal:  BMJ Paediatr Open       Date:  2019-06-27

6.  Factors Associated with Triage Modifications Using Vital Signs in Pediatric Triage: a Nationwide Cross-Sectional Study in Korea.

Authors:  Bongjin Lee; Ikwan Chang; Do Kyun Kim; June Dong Park
Journal:  J Korean Med Sci       Date:  2020-04-27       Impact factor: 2.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.